Tag: Asahi Kasei

Asahi Kasei Life Science Acquires License for Novel Antibody-Drug Conjugate Technology from The Noguchi Institute – A Major Milestone for More Efficient and Safer Cancer Treatments

29 May 2026 No Comments

TOKYO – May 27, 2026 – Asahi Kasei Life Science has acquired the license

Asahi Kasei Pharma Strengthens Preclinical Pipeline Through Exclusive Global License Agreement with Alchemedicine for Novel Lead Compounds

27 February 2026 No Comments

TOKYO – February 25, 2026 – Asahi Kasei Pharma announced that it has strengthened

Asahi Kasei Pharma and Alchemedicine advance a novel therapeutic candidate into Phase I study for the treatment of refractory diseases

20 February 2026 No Comments

TOKYO – February 18, 2026 – Asahi Kasei Pharma, a global provider of healthcare

Asahi Kasei, Mitsui Chemicals, and Mitsubishi Chemical enter basic agreement to promote decarbonization of ethylene production in western Japan – Leveraging METI’s “Fiscal 2025 Support Program for Energy and Manufacturing Process Conversion in Hard-to-Abate Industries”

28 January 2026 No Comments

Tokyo – January 27, 2026 – Asahi Kasei, Mitsui Chemicals, and Mitsubishi Chemical have